Table 4 Aminoacid concentration based on Genes, Genotype and p.(Pro482Leu) variant.

From: Genetic and clinical characteristics of Japanese cystinuria with exon and exon–intron boundary variants

Urine Amino acids: µmol/day

 

Cystine

 

Ornithine

 

Lysine

 

Arginine

 
 

Median

Range

Median

Range

Median

Range

Median

Range

Based on genes

SLC3A1

1357.2

(186.9–3117.9)

1692.6

(861.3–3848.1)

7051.8

(5307.9–12456.4)

2682.7

(323.4–4590.5)

SLC7A9

1832.2

(184.6–5303.4)

2020.15

(205.2–7471.7)

8787.8

(536.9–36961.6)

3334.2

(96.3–12096)

SLC3A1/SLC7A9

1434

(1037.3–3722.9)

3174.4

(2302.1–4316.8)

8144

(1300.2–13826.2)

3495.9

(2269–5996.8)

Based on genotype

AA

1230.6

(186.9–3117.9)

1355.8

(861.3–3848.1)

5631.6

(5307.9–9223.1)

1002.9

(323.4–4590.5)

BB

1815.45

(184.6–5303.4)

2036.8

(205.2–7417.7)

8858.5

(536.9–36,961.6)

3334.2

(150.4–12096)

AAB/BBA

1434

(1037.3–3722.9)

3174.4

(2302.1–4316.8)

8144

(1300.2–13826.2)

3495.9

(2269–5996.8)

A

3034.6

(3034.6–3034.6)

2029.4

(2029.4–2029.4)

12,456.4

(12456.5–12456.5)

4425.4

(4425.4–4425.4)

B

1968.8

(592.8–4094.2)

1616.4

(278.3–2843)

8576.3

(3038.4–10211.1)

555.9

(96.3–5037.6)

Based on p.(Pro482Leu)

p.(Pro482Leu) Homo

1705.15

(184.6–4368)

2195.6

(205.2–4316.8)

8858.5

(536.9–17412)

3423.4

(150.4–6531)

p.(Pro482Leu) compound hetero

2359.3

(851–5303.4)

2183.1

(716–7471.7)

8970.1

(2968.4–36961.6)

3875.3

(1416.6–12096)

p.(Pro482Leu) single Hetero

1280.8

(592.8–1968.8)

1560.65

(278.3–2843)

5807.4

(3038.4–8576.3)

2567

(96.3–5037.6)

None p.(Pro482Leu)

1483.7

(186.9–4094.2)

1822.9

(845.4–5497.2)

8594.5

(2411.5–16476.1)

1729.4

(323.4–9512.9)